Global Glycated Albumin Assay Market Forecast Report to 2028 - Market Poised for Strong Growth with Prediabetes Segment Driving Global Demand by 2028

News provided by

Jan 15, 2024, 11:00 ET

DUBLIN, Jan. 15, 2024 /PRNewswire/ -- The "Global Glycated Albumin Assay Market by Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End-user (Hospitals & Diabetic Care Center, Diagnostic Laboratory) and Region - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

The global glycated albumin assay market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 8.9% during the forecast period.

Market growth is driven by factors such as the increased number of diabetic patients above the age of 65 years and government initiatives for disease diagnosis. On the other hand, challenges associated with the glycated albumin assay market, like unfavorable reimbursement scenarios, are the major factors restricting market growth.

The prediabetic segment accounted for the highest growth rate in the glycated albumin assay market, by application, during the forecast period

The glycated albumin assay market is segmented into prediabetes, type 1 diabetes, and type 2 diabetes. In 2022, the prediabetes segment accounted for the highest glycated albumin assay market growth rate. The increasing focus on the prevention of lifestyle diseases like diabetes, growth in the number of diagnostic laboratories, and improving healthcare infrastructure in emerging countries are major factors contributing to this segment's growth.

The diagnostic laboratories segment accounted for the highest growth in the glycated albumin assay market, by end-user, during the forecast period

The glycated albumin assay market is segmented into hospitals and diabetes care centers, diagnostic laboratories, and other end-user based on end-users. In 2022, the diagnostic laboratories segment accounted for the highest glycated albumin assay market growth rate. Diagnostics laboratories often offer cost-effective and convenient testing options for healthcare providers and patients. By outsourcing glycated albumin testing to diagnostics laboratories, healthcare providers can avoid the need for in-house testing facilities and associated costs. Additionally, patients can visit diagnostics laboratories for their glycated albumin assays without the need for hospitalization or specialized clinic visits. The cost-effectiveness and convenience of diagnostics laboratories make them an attractive option, leading to increased demand and segment growth.

Asia-Pacific: the fastest-growing region in glycated albumin assay market

The North American, European, Asia-Pacific, Latin American, Middle Eastern, and African regions make up the major segments of the worldwide glycated albumin assay market. The highest CAGR is anticipated to be recorded over the forecast period in the Asia-Pacific region. The glycated albumin assay market in this region is expanding as a result of an increase in diabetes awareness programmes and favourable government healthcare policies.

Key Topics Covered:

Executive Summary

Glycated Albumin Assay Market, by Application, 2023 vs. 2028 (USD Million)
Glycated Albumin Assay Market, by End-user, 2023 vs. 2028 (USD Million)
Glycated Albumin Assay Market, by Region, 2023 vs. 2028 (USD Million)

Premium Insights

Glycated Albumin Assay Market Overview - Increasing Prevalence of Diabetes to Drive Market
Glycated Albumin Assay Market, by Application, 2023 vs. 2028 - Type 2 Diabetes Segment to Dominate Market During Forecast Period
Glycated Albumin Assay Market, by End-user, 2023 vs. 2028 - Hospitals and Diabetic Care Centers Segment to Dominate Market During Forecast Period
Glycated Albumin Assay Market: Geographical Growth Opportunities - Asia-Pacific to Register Highest CAGR During Forecast Period

Market Dynamics

Drivers

Rising Incidence of Diabetes
Growing Focus on Early Detection of Diabetes
Increase in Age-Associated Diabetic Ailments

Restraints

Unfavorable Reimbursement Scenario

Opportunities

Rising Investments in Life Sciences Research

Challenges

Stringent Regulatory Requirements for Diagnostic Products
Presence of Alternative Tests

Company Profiles

Asahi Kasei
Beijing Strong Biotechnologies
Diazyme Laboratories
DxGen Corp.
Hzymes Biotech
Weldon Biotech

For more information about this report visit https://www.researchandmarkets.com/r/iwls3w

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets